These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17094930)

  • 21. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of bipolar mania with atypical antipsychotics.
    Chengappa KN; Suppes T; Berk M
    Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S17-25. PubMed ID: 16279862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine for acute mania in bipolar disorder.
    Brahm NC; Gutierres SL; Carnahan RM
    Am J Health Syst Pharm; 2007 May; 64(10):1045-53. PubMed ID: 17494904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects.
    Srivastava S; Ketter TA
    Clin Ther; 2011 Dec; 33(12):B40-8. PubMed ID: 22177379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.
    Smith LA; Cornelius V; Warnock A; Tacchi MJ; Taylor D
    Bipolar Disord; 2007 Sep; 9(6):551-60. PubMed ID: 17845269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis.
    Glue P; Herbison P
    Aust N Z J Psychiatry; 2015 Dec; 49(12):1215-20. PubMed ID: 26546499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics: newer options for mania and maintenance therapy.
    Vieta E; Goikolea JM
    Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of antimanic treatments in mixed states.
    McIntyre RS; Yoon J
    Bipolar Disord; 2012 May; 14 Suppl 2():22-36. PubMed ID: 22510034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic agents for the treatment of acute bipolar mania.
    McElroy SL; Keck PE
    Biol Psychiatry; 2000 Sep; 48(6):539-57. PubMed ID: 11018226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bipolar drug development: are we getting closer to the real world?
    Calabrese JR; Kemp DE
    Am J Psychiatry; 2008 Oct; 165(10):1234-6. PubMed ID: 18829876
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.
    Yatham LN
    Bipolar Disord; 2003; 5 Suppl 2():7-19. PubMed ID: 14700009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lithium and anticonvulsants in bipolar depression].
    Samalin L; Nourry A; Llorca PM
    Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.